Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Sen. D'Amato considering bill to classify euphoria-producing supplements as drugs.

This article was originally published in The Tan Sheet

Executive Summary

SEN. D'AMATO CONSIDERING BILL TO CLASSIFY EUPHORIA-PRODUCING SUPPLEMENTS AS DRUGS in the wake of recent problems associated with ephedrine-containing stimulant products in Florida and New York. Florida is banning the sale of such products, as is New York's Nassau County. As currently written by Sen. Alfonse D'Amato (R-N.Y.), the draft bill would amend the FD&C Act to "clarify that any dietary supplement that claims to produce euphoria, heightened awareness or similar mental or psychological effects shall be treated as a drug."





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts